Core Viewpoint - Shandong Xinhua Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for the transfer of the marketing authorization of artificial bile acid metronidazole capsules [1] Group 1 - The product in question is referred to as "artificial bile acid metronidazole capsules" [1] - The approval allows for the transfer of the supplementary application for the marketing authorization holder [1] - The application complies with the relevant requirements for drug registration as per the Drug Administration Law of the People's Republic of China [1]

Core Viewpoint - Shandong Xinhua Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for the transfer of the marketing authorization of artificial bile acid metronidazole capsules, indicating compliance with post-marketing change management requirements [1] Group 1: Company Developments - The company submitted a supplementary application for the change of marketing authorization holder in March 2026, which has now been approved [1] - The approval allows the company to transfer the marketing authorization for the product, which is indicated for acute pericoronitis, local alveolar abscess, pulpitis, and apical periodontitis [1] Group 2: Market Insights - The sales revenue of artificial bile acid metronidazole capsules in Chinese public medical institutions is projected to be approximately RMB 579 million in 2024 [1]

Core Viewpoint - There is a significant price discrepancy between online and offline pharmacies for the same medications, with some prices being more than three times higher in physical stores compared to online platforms [1][2][5]. Group 1: Price Discrepancy - A survey of ten pharmacies revealed that the same medication can have a price difference of over three times between online and offline sales [1][6]. - For example, the "仁和" artificial cow bile metronidazole capsules cost 8.68 yuan online but 32 yuan offline, resulting in a difference of 23.32 yuan [1][6]. - Other examples include "可益甘" artificial cow bile metronidazole capsules priced at 5.8 yuan online and 15.8 yuan offline, and "百多邦" mupirocin ointment at 19.2 yuan online versus 23.2 yuan offline [5][6]. Group 2: Reasons for Price Differences - Pharmacy staff indicated that online prices are often lower due to platform subsidies, although not all medications follow this trend [2][9]. - Consumers have the option to choose between online and offline purchases based on their preferences, but online shopping may incur additional delivery fees [2][9]. - Legal experts noted that the price difference alone does not constitute price fraud; it must be assessed in the context of whether the pharmacy transparently communicates the reasons for the price difference [11][12]. Group 3: Regulatory Responses - The National Medical Insurance Administration has issued directives to compare offline pharmacy prices with online platforms to address unreasonable pricing [10]. - Local regulations have been established, such as in Shaanxi Province, where offline prices cannot exceed 20% of the online price displayed by the same pharmacy [10]. - Zhejiang Province has mandated that online prices should not exceed 1.3 times the listed price, emphasizing the need for price consistency across different sales channels [10].

Core Insights - There is a significant price discrepancy between online and offline sales of the same medication, with some offline prices being over three times higher than online prices [1] - The price differences are attributed to subsidies provided by online platforms, although not all medications follow this trend [1] - Regulatory measures have been implemented to ensure that offline prices do not exceed a certain percentage above online prices, promoting price consistency [1] Group 1 - The price of "Renhe" artificial cow bile capsules (12 capsules * 2 packs) at a physical store is 32 yuan, while the online price is only 8.68 yuan, resulting in a price difference of 23.32 yuan [1] - Staff from various pharmacies indicated that the lower online prices are due to platform subsidies, and consumers have the option to choose based on their needs [1] - There are policies in place requiring that the offline retail prices of medications be compared with online prices, and any significant discrepancies should prompt adjustments by pharmaceutical companies [1] Group 2 - Some local regulations mandate that the offline sales price at designated pharmacies should not exceed 20% above the price displayed on online platforms [1] - The presence of minimum order requirements for online purchases can offset the perceived savings from online shopping [1] - The overall trend indicates a growing scrutiny of pricing practices in the pharmaceutical retail sector, aiming to protect consumer interests [1]